HLB Eperisone Tablet (Eperisone Hydrochloride)

Adult dose

As Eperisone Hydrochloride, take 50 mg orally three times a day after meals. Adjust dosage appropriately based on age and symptoms.

This drug should not be used in certain patients. First, it must not be administered to patients with allergic reactions to this medication or those with myasthenia gravis. Additionally, this medication contains lactose and should not be used in patients with galactose intolerance, lactose deficiency, or glucose-galactose malabsorption, which are genetic metabolic disorders. When using this drug, caution should be exercised in patients with a history of drug hypersensitivity and those with impaired liver function. Patients with liver dysfunction may need to be careful as their liver function may worsen. While taking this medication, various adverse reactions may occur, so careful observation is required. Rarely, shock reactions may occur, and if symptoms appear, the administration should be immediately stopped, and appropriate treatment should be received. It is also possible to experience elevated liver enzymes, kidney dysfunction, and blood-related issues such as anemia. Various symptoms may arise, including skin rash or itching, insomnia, drowsiness, headache, nausea, vomiting, constipation, diarrhea, abdominal pain, abdominal bloating, stomatitis, urinary retention, incontinence, sense of residual urine, weakness, dizziness, general malaise, and decreased muscle tone, facial flushing, sweating, and edema. Especially serious skin adverse reactions such as toxic epidermal necrolysis syndrome and Stevens-Johnson syndrome can occur, so if symptoms such as fever, skin rash, blisters, conjunctival injection, or stomatitis develop, the medication should be stopped immediately, and a hospital visit is necessary. While taking this medication, drowsiness or decreased concentration may occur, so it is advisable to avoid driving or operating hazardous machinery. Furthermore, caution is warranted when taken with similar medications, as visual disturbances may occur. Women who are pregnant or may become pregnant should only use this medication when the benefits of treatment outweigh the risks, as its safety has not been fully established. If breastfeeding, it is recommended to avoid administration if possible, and if unavoidable, to discontinue breastfeeding. In children, safety has not been sufficiently confirmed, and there is limited experience with usage, so caution is needed. In elderly patients, special care is necessary due to the possible decline in physical function, including dose reduction.

Serious side effects

Shock, anaphylactic reactions, angioedema, toxic epidermal necrolysis and mucocutaneous-ocular syndrome (Stevens-Johnson syndrome), liver abnormalities (elevated ALT, AST, ALP), kidney abnormalities (proteinuria, elevated BUN), anemia.

Mild side effects

• Occasionally
• rash
• itching
• insomnia
• drowsiness
• headache
• muscle stiffness
• limb tremors
• nausea
• vomiting

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is best to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle